Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bristol-Myers Squibb reports new KCNA5 blockers

Oct. 10, 2014

A team of scientists in Taipai designs new polypeptides for C. difficile infection

Oct. 10, 2014

Novel PDH kinase inhibitors patented at Japan Tobacco

Oct. 10, 2014

Vertex patents novel ATR inhibitors for cancer

Oct. 10, 2014

New ROR-gamma receptor modulators patented by Roche and Genentech

Oct. 10, 2014

Scientists at Roche synthesize novel autotaxin inhibitors

Oct. 9, 2014

Takeda Pharmaceutical divulges novel ROR-gamma antagonists

Oct. 9, 2014

Aurigene Discovery Technologies designs new NAmPRTase inhibitors

Oct. 9, 2014

Novel pyrrolotriazines disclosed by Bristol-Myers Squibb for arrhythmia

Oct. 9, 2014

Deciphera Pharmaceuticals patents novel agents for cancer and other disorders

Oct. 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...